The findings suggested that CPT-1A expression and methylation is negatively associated with these cells, suggesting that survival and prognosis may be affected by inhibiting tumor-infiltrating lymphocytes (TILs) response (Das et al., 2022). This evidence concerns the gene CPT1A and neoplasm.